Immunotherapy Effective Against Stomach Cancer
FRIDAY, June 6, 2025 (HealthDay News) — Immunotherapy combined with chemo can give people a fighting chance against stomach and esophageal cancers, a new clinical trial says. People treated with durvalumab and chemotherapy were much more likely to go into remission, according to clinical trial results published June 1 in Continue Reading